| Patents for C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294) |
|---|
| 03/14/2012 | EP2427431A1 Novel indicator platform |
| 03/13/2012 | CA2486539C C-aryl glucoside sglt2 inhibitors and method |
| 03/13/2012 | CA2480468C Fredericamycin derivatives |
| 03/01/2012 | WO2012025857A1 Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors |
| 03/01/2012 | US20120053336 Nucleic Acid Labelling Compounds |
| 03/01/2012 | US20120053132 Compositions and methods for inhibiting cytochrome p450 |
| 02/16/2012 | WO2012019496A1 C-aryl glucoside derivatives, preparation rpocess and pharmaceutical use thereof |
| 02/16/2012 | CA2807034A1 C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof |
| 02/15/2012 | CN102351918A Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture |
| 02/14/2012 | US8114970 Synthetic heparin monosaccharides |
| 02/09/2012 | US20120035346 Luminescent compounds |
| 02/08/2012 | CN102344468A Preparation and use of novel AKT/PKB kinase agonists |
| 02/02/2012 | US20120029183 Sulfated c-glycoside, method for isolating same and method for synthesizing same |
| 02/02/2012 | US20120027857 Controlled release pharmaceutical compositions comprising o-desmethyl-venlafaxine |
| 01/31/2012 | CA2550373C Anti-hypercholesterolemic compounds |
| 01/26/2012 | US20120022016 Compounds and methods for selectively targeting tumor-associated mucins |
| 01/26/2012 | US20120021430 Functional lipid constructs |
| 01/26/2012 | US20120020921 1'-substituted-carba-nucleoside prodrugs for antiviral treatment |
| 01/25/2012 | CN101880299B Purification method of Bajisin |
| 01/12/2012 | WO2012003811A1 C-aryl glucoside sglt2 inhibitors and method |
| 01/12/2012 | US20120009147 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 01/11/2012 | EP2404894A1 Mevalonic Acid Derivatives |
| 01/11/2012 | CN102317302A Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics |
| 01/11/2012 | CN102317301A Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics |
| 01/11/2012 | CN101671372B Esterification reaction synthetic method of oligomeric propylene diester and oligomeric propylene diester thereof |
| 01/05/2012 | US20120004405 Compounds having activity in correcting mutant cftr cellular processing |
| 01/05/2012 | US20120004193 Process for production of orally ingestible composition containing arabinofuranosyl vitexin, and use of the composition |
| 01/03/2012 | CA2519568C 6"-amino-6"-deoxygalactosylceramides |
| 12/28/2011 | EP2399900A1 Geranyl compounds |
| 12/28/2011 | EP2399899A1 Geranyl compounds |
| 12/28/2011 | EP2010537B1 Imidazoquinoxaline compounds as immunomodulators |
| 12/28/2011 | CN101691410B 一种具有防治胰岛素抵抗作用的海洋寡糖铬配合物 Having a role in prevention and treatment of insulin resistance in marine oligosaccharides chromium complexes |
| 12/22/2011 | WO2011157746A1 Cosmetic antioxidant aromatic c-glycosides |
| 12/15/2011 | WO2011153953A1 Crystalline form of benzylbenzene sglt2 inhibitor |
| 12/15/2011 | WO2011153712A1 Crystalline form of benzylbenzene sglt2 inhibitor |
| 12/15/2011 | US20110306759 4-isopropylphenyl glucitol compounds as sglt1 inhibitors |
| 12/15/2011 | CA2800379A1 Crystalline form of benzylbenzene sglt2 inhibitor |
| 12/13/2011 | US8076072 Nucleic acid labeling compounds |
| 12/08/2011 | US20110301109 Phenylpyrimidone Compounds, the Pharmaceutical Compositions, Preparation Methods and Uses Thereof |
| 12/07/2011 | CN101500580B 具有增强的Th-1模式的C-糖脂 C- glycolipids having enhanced Th-1 mode |
| 12/01/2011 | US20110293563 1'substituted carba-nucleoside analogs for antiviral treatment |
| 11/30/2011 | CN102264714A 制备可用作sglt抑制剂的化合物的方法 Preparation of the compounds useful as inhibitors of a method sglt |
| 11/30/2011 | CN102260297A 海藻糖酰胺衍生物及其制备方法与应用 Trehalose derivatives and their preparation and use |
| 11/29/2011 | CA2519797C Low molecular weight hyaluronic acid for the treatment of nerve damage |
| 11/16/2011 | CN102245622A Novel aryl C-xyloside compounds, and cosmetic use |
| 11/16/2011 | CN102241709A High efficiency separation method for shcaftoside |
| 11/15/2011 | CA2508468C Nucleosides or nucleotides having novel unnatural bases and use thereof |
| 11/09/2011 | CN102234296A Preparation method of schaftoside and isoschaftoside |
| 11/08/2011 | CA2493690C Synthetic c-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases |
| 11/03/2011 | US20110269700 Glucoside derivatives and uses thereof |
| 11/01/2011 | CA2671357C Crystalline form of 1-(.beta.-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate |
| 10/26/2011 | EP2183263B1 Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors |
| 10/19/2011 | EP2376512A2 Derivatives of morphine-6-glucuronid, process for their preparation and their use in therapy |
| 10/19/2011 | EP2376511A2 Bicyclic derivatives of morphine-6-glucuronid, process for their preparation and their application in therapy |
| 10/19/2011 | EP2376510A1 Novel aryl c-xyloside compounds, and cosmetic use |
| 10/19/2011 | CN102219809A Rectification and crystallization method of glucurolactone |
| 10/13/2011 | US20110251363 Stereoregular romp polymers |
| 10/12/2011 | EP2373672A1 Novel flavour enhancer compounds |
| 10/12/2011 | EP2373670A2 Novel amino substituted c-glycoside derivatives and use thereof as cosmetic |
| 10/12/2011 | CN101429111B Comprehensive processing method and apparatus for mother solution in production of glucurolactone |
| 10/06/2011 | US20110245490 C-glycoside compounds, and method for preparing c-glycoside compounds |
| 09/29/2011 | WO2011057192A3 Amphiphilic compositions and methods for preparing and using same |
| 09/29/2011 | US20110237789 Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives |
| 09/29/2011 | US20110237785 Spatially-defined macrocyclic compounds useful for drug discovery |
| 09/29/2011 | US20110237657 Transport-Mediating Colloidal Pharmaceutical Compounds |
| 09/29/2011 | US20110237529 Adenosine Analogs and Their Use |
| 09/29/2011 | US20110237527 Sglt-2 inhibitors, methods of making them, and uses thereof |
| 09/29/2011 | US20110237526 Method for the preparation of a crystalline form |
| 09/27/2011 | US8026057 Nucleic acid labeling compounds |
| 09/22/2011 | US20110230654 Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs |
| 09/22/2011 | US20110230403 Glycoside derivatives and uses thereof |
| 09/22/2011 | US20110229409 Linkable lewis x analogs |
| 09/21/2011 | EP1631537B1 Method for selective carbohydrate oxidation using supported gold catalysts |
| 09/15/2011 | US20110224169 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 09/15/2011 | DE102010006245A1 Herstellung und Verwendung antibakterieller, antiproliferativer und antiphytopathogener Benzanthrine Production and use antibacterial, anti-proliferative and antiphytopathogenic Benzanthrine |
| 09/09/2011 | WO2011107494A1 Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof |
| 09/06/2011 | US8013147 Heterocyclic compounds and their use in the detection of nucleic acids |
| 09/06/2011 | US8012941 Carba-nucleoside analogs for antiviral treatment |
| 09/01/2011 | US20110212906 C-linked glucuronide of n-(4-hydroxybenzyl) retinone, analogs thereof, and methods of using the same to inhibit neoplastic cell growth |
| 09/01/2011 | US20110212905 Crystalline form of 1-(beta-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate |
| 08/31/2011 | EP2361920A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 08/31/2011 | CN102167715A Eutectic preparation method of sodium-glucose cotransporter 2 bulk pharmaceutical chemicals |
| 08/30/2011 | US8008264 1′-substituted carba-nucleoside analogs for antiviral treatment |
| 08/24/2011 | EP2360165A2 Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 08/24/2011 | EP2360164A2 Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof |
| 08/18/2011 | US20110201795 Methods of Producing C-Aryl Glucoside SGLT2 Inhibitors |
| 08/17/2011 | EP2357184A1 Imidazoquinoxaline compounds as immunomodulators |
| 08/11/2011 | WO2011095050A1 C-glycoside derivatives containing saturated 6-member rings, preparation methods and uses thereof |
| 08/11/2011 | WO2010043682A3 Process for the preparation of compounds useful as inhibitors of sglt |
| 08/10/2011 | EP1471052B1 Geranyl compounds |
| 08/04/2011 | WO2011091710A1 Phenyl c-glucoside derivatives, preparation methods and uses thereof |
| 08/03/2011 | EP2351763A1 Method for extraction of compound containing sialic acid from plant |
| 08/03/2011 | EP2350108A2 C-glycoside compounds, and method for preparing c-glycoside compounds |
| 08/03/2011 | EP2013624B1 Method for the identification of new leads for drug candidates |
| 08/02/2011 | CA2414211C Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 07/27/2011 | EP2346888A2 Process for the preparation of compounds useful as inhibitors of sglt |
| 07/27/2011 | CN101065391B C-aryl glucoside sglt2 inhibitors and method |
| 07/21/2011 | US20110178033 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 07/21/2011 | US20110177154 Tubular nanostructure targeted to cell membrane |
| 07/20/2011 | CN1944448B Puerarin derivative and its medicinal use |